|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
312 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Abemaciclib/prednisolone |
|
1894 | 1 |
p. 14 |
artikel |
||
| 2 | Acetazolamide |
|
1894 | 1 |
p. 15 |
artikel |
||
| 3 | Acetazolamide/estrogen |
|
1894 | 1 |
p. 16 |
artikel |
||
| 4 | Aciclovir |
|
1894 | 1 |
p. 17 |
artikel |
||
| 5 | Adalimumab |
|
1894 | 1 |
p. 19 |
artikel |
||
| 6 | Adalimumab/azathioprine/corticosteroids |
|
1894 | 1 |
p. 20 |
artikel |
||
| 7 | Adalimumab/thalidomide |
|
1894 | 1 |
p. 21 |
artikel |
||
| 8 | Adalimumab/ustekinumab/vedolizumab |
|
1894 | 1 |
p. 22 |
artikel |
||
| 9 | Ad26.COV2-S |
|
1894 | 1 |
p. 18 |
artikel |
||
| 10 | Adenosine |
|
1894 | 1 |
p. 23 |
artikel |
||
| 11 | Aflibercept |
|
1894 | 1 |
p. 24 |
artikel |
||
| 12 | Agalsidase-beta |
|
1894 | 1 |
p. 25 |
artikel |
||
| 13 | Albumin-human/thalidomide |
|
1894 | 1 |
p. 26 |
artikel |
||
| 14 | Alcohol |
|
1894 | 1 |
p. 27 |
artikel |
||
| 15 | Alectinib |
|
1894 | 1 |
p. 28 |
artikel |
||
| 16 | Alteplase/epoprostenol |
|
1894 | 1 |
p. 29 |
artikel |
||
| 17 | Aminolevulinic acid/lidocaine |
|
1894 | 1 |
p. 30 |
artikel |
||
| 18 | Amisulpride/aripiprazole/quetiapine |
|
1894 | 1 |
p. 31 |
artikel |
||
| 19 | Amoxicillin/clavulanic-acid/methotrexate |
|
1894 | 1 |
p. 32 |
artikel |
||
| 20 | Amphotericin-B-liposomal/posaconazole |
|
1894 | 1 |
p. 33 |
artikel |
||
| 21 | Anastrozole |
|
1894 | 1 |
p. 34 |
artikel |
||
| 22 | Antiarrhythmics/beta-adrenergic-receptor-antagonists |
|
1894 | 1 |
p. 35 |
artikel |
||
| 23 | Antibacterials |
|
1894 | 1 |
p. 36 |
artikel |
||
| 24 | Antibiotics/antifungal therapy |
|
1894 | 1 |
p. 37 |
artikel |
||
| 25 | Antidepressants and antipsychotics rarely associated with delirium |
|
1894 | 1 |
p. 3 |
artikel |
||
| 26 | Antidepressants/antipsychotics/anxiolytics |
|
1894 | 1 |
p. 38 |
artikel |
||
| 27 | Antineoplastics |
|
1894 | 1 |
p. 44 |
artikel |
||
| 28 | Antineoplastics |
|
1894 | 1 |
p. 40 |
artikel |
||
| 29 | Antineoplastics |
|
1894 | 1 |
p. 42 |
artikel |
||
| 30 | Antineoplastics |
|
1894 | 1 |
p. 41 |
artikel |
||
| 31 | Antineoplastics |
|
1894 | 1 |
p. 39 |
artikel |
||
| 32 | Antineoplastics |
|
1894 | 1 |
p. 43 |
artikel |
||
| 33 | Antineoplastics/antibacterials |
|
1894 | 1 |
p. 45 |
artikel |
||
| 34 | Antineoplastics/chloroquine |
|
1894 | 1 |
p. 46 |
artikel |
||
| 35 | Antineoplastics/levetiracetam/pregabalin |
|
1894 | 1 |
p. 47 |
artikel |
||
| 36 | Antiparkinsonians |
|
1894 | 1 |
p. 48 |
artikel |
||
| 37 | Antirheumatics |
|
1894 | 1 |
p. 49 |
artikel |
||
| 38 | Antivirals |
|
1894 | 1 |
p. 50 |
artikel |
||
| 39 | Antivirals/immunosuppressants |
|
1894 | 1 |
p. 51 |
artikel |
||
| 40 | Apixaban/nitrofurantoin/warfarin |
|
1894 | 1 |
p. 52 |
artikel |
||
| 41 | ART-associated ADRs frequent in children with HIV infection in India |
|
1894 | 1 |
p. 4 |
artikel |
||
| 42 | Aspirin |
|
1894 | 1 |
p. 53 |
artikel |
||
| 43 | Atenolol |
|
1894 | 1 |
p. 54 |
artikel |
||
| 44 | Atezolizumab |
|
1894 | 1 |
p. 55 |
artikel |
||
| 45 | Atezolizumab/methylprednisolone interaction |
|
1894 | 1 |
p. 56 |
artikel |
||
| 46 | Atorvastatin/prednisolone |
|
1894 | 1 |
p. 57 |
artikel |
||
| 47 | Azathioprine/dapsone/methylprednisolone |
|
1894 | 1 |
p. 58 |
artikel |
||
| 48 | Azathioprine/methylprednisolone |
|
1894 | 1 |
p. 59 |
artikel |
||
| 49 | AZD-1222 |
|
1894 | 1 |
p. 63 |
artikel |
||
| 50 | Azd-1222 |
|
1894 | 1 |
p. 64 |
artikel |
||
| 51 | AZD-1222 |
|
1894 | 1 |
p. 60 |
artikel |
||
| 52 | Azd-1222 |
|
1894 | 1 |
p. 62 |
artikel |
||
| 53 | AZD-1222 |
|
1894 | 1 |
p. 66 |
artikel |
||
| 54 | AZD-1222 |
|
1894 | 1 |
p. 65 |
artikel |
||
| 55 | Azd-1222 |
|
1894 | 1 |
p. 70 |
artikel |
||
| 56 | AZD-1222 |
|
1894 | 1 |
p. 67 |
artikel |
||
| 57 | AZD-1222 |
|
1894 | 1 |
p. 68 |
artikel |
||
| 58 | Azd-1222 |
|
1894 | 1 |
p. 61 |
artikel |
||
| 59 | Azd-1222 |
|
1894 | 1 |
p. 69 |
artikel |
||
| 60 | Azd-1222/bbv-152 |
|
1894 | 1 |
p. 71 |
artikel |
||
| 61 | Azd-1222/covid-19-vaccine-pfizer-biontech |
|
1894 | 1 |
p. 72 |
artikel |
||
| 62 | BCG/gemcitabine |
|
1894 | 1 |
p. 74 |
artikel |
||
| 63 | BCG vaccine |
|
1894 | 1 |
p. 73 |
artikel |
||
| 64 | Bendamustine/rabies-immune-globulin/rituximab |
|
1894 | 1 |
p. 75 |
artikel |
||
| 65 | Betamethasone/tenofovir |
|
1894 | 1 |
p. 76 |
artikel |
||
| 66 | Bevacizumab |
|
1894 | 1 |
p. 78 |
artikel |
||
| 67 | Bevacizumab |
|
1894 | 1 |
p. 77 |
artikel |
||
| 68 | Botulinum-Toxin-A |
|
1894 | 1 |
p. 79 |
artikel |
||
| 69 | Botulinum-toxin-a |
|
1894 | 1 |
p. 80 |
artikel |
||
| 70 | Brigatinib/cetuximab/osimertinib |
|
1894 | 1 |
p. 81 |
artikel |
||
| 71 | Budesonide/methylprednisolone |
|
1894 | 1 |
p. 82 |
artikel |
||
| 72 | Budesonide/pembrolizumab/rituximab |
|
1894 | 1 |
p. 83 |
artikel |
||
| 73 | Bupropion |
|
1894 | 1 |
p. 84 |
artikel |
||
| 74 | Cabozantinib/sorafenib |
|
1894 | 1 |
p. 85 |
artikel |
||
| 75 | Calcium gluconate |
|
1894 | 1 |
p. 86 |
artikel |
||
| 76 | Camrelizumab |
|
1894 | 1 |
p. 87 |
artikel |
||
| 77 | Canakinumab |
|
1894 | 1 |
p. 88 |
artikel |
||
| 78 | Capecitabine |
|
1894 | 1 |
p. 89 |
artikel |
||
| 79 | Caplacizumab |
|
1894 | 1 |
p. 90 |
artikel |
||
| 80 | Capmatinib |
|
1894 | 1 |
p. 91 |
artikel |
||
| 81 | Carbamazepine |
|
1894 | 1 |
p. 92 |
artikel |
||
| 82 | Carboplatin/immunosuppressants/pembrolizumab |
|
1894 | 1 |
p. 93 |
artikel |
||
| 83 | Carboplatin/paclitaxel |
|
1894 | 1 |
p. 94 |
artikel |
||
| 84 | Carboplatin/paclitaxel/pembrolizumab |
|
1894 | 1 |
p. 95 |
artikel |
||
| 85 | Catequentinib |
|
1894 | 1 |
p. 96 |
artikel |
||
| 86 | Cefalexin/flucloxacillin/sucrose |
|
1894 | 1 |
p. 97 |
artikel |
||
| 87 | Cefepime |
|
1894 | 1 |
p. 98 |
artikel |
||
| 88 | Cefepime |
|
1894 | 1 |
p. 99 |
artikel |
||
| 89 | Ceftriaxone |
|
1894 | 1 |
p. 100 |
artikel |
||
| 90 | Cemiplimab/pembrolizumab |
|
1894 | 1 |
p. 101 |
artikel |
||
| 91 | Cetuximab |
|
1894 | 1 |
p. 102 |
artikel |
||
| 92 | Cetuximab/encorafenib |
|
1894 | 1 |
p. 103 |
artikel |
||
| 93 | Ciclosporin |
|
1894 | 1 |
p. 104 |
artikel |
||
| 94 | Ciclosporin/methotrexate/mycophenolate mofetil |
|
1894 | 1 |
p. 105 |
artikel |
||
| 95 | Ciclosporin/prednisolone |
|
1894 | 1 |
p. 106 |
artikel |
||
| 96 | Ciclosporin/prednisolone/prednisone |
|
1894 | 1 |
p. 107 |
artikel |
||
| 97 | Ciprofloxacin/levofloxacin/moxifloxacin |
|
1894 | 1 |
p. 108 |
artikel |
||
| 98 | Ciprofloxacin/tozinameran |
|
1894 | 1 |
p. 109 |
artikel |
||
| 99 | Cisplatin/crizotinib/pemetrexed |
|
1894 | 1 |
p. 110 |
artikel |
||
| 100 | Cisplatin/fluorouracil/paclitaxel |
|
1894 | 1 |
p. 111 |
artikel |
||
| 101 | Clarithromycin/lacidipine interaction |
|
1894 | 1 |
p. 112 |
artikel |
||
| 102 | Clindamycin |
|
1894 | 1 |
p. 113 |
artikel |
||
| 103 | Clotrimazole/dexamethasone/neomycin |
|
1894 | 1 |
p. 114 |
artikel |
||
| 104 | Clozapine |
|
1894 | 1 |
p. 115 |
artikel |
||
| 105 | Convalescent-anti-sars-cov-2-plasma |
|
1894 | 1 |
p. 116 |
artikel |
||
| 106 | Coronavirus-vaccine |
|
1894 | 1 |
p. 117 |
artikel |
||
| 107 | COVID-19 Vaccine Pfizer BioNTech |
|
1894 | 1 |
p. 119 |
artikel |
||
| 108 | COVID-19-Vaccine-Pfizer-BioNTech |
|
1894 | 1 |
p. 120 |
artikel |
||
| 109 | COVID-19 Vaccine Pfizer BioNTech |
|
1894 | 1 |
p. 118 |
artikel |
||
| 110 | COVID-19-Vaccine-Pfizer-BioNTech |
|
1894 | 1 |
p. 121 |
artikel |
||
| 111 | Cyclophosphamide/docetaxel/doxorubicin |
|
1894 | 1 |
p. 122 |
artikel |
||
| 112 | Dabrafenib/trametinib |
|
1894 | 1 |
p. 123 |
artikel |
||
| 113 | Dabrafenib/trametinib/pembrolizumab |
|
1894 | 1 |
p. 124 |
artikel |
||
| 114 | Daptomycin |
|
1894 | 1 |
p. 125 |
artikel |
||
| 115 | Dasatinib |
|
1894 | 1 |
p. 126 |
artikel |
||
| 116 | Daunorubicin/doxorubicin/epirubicin |
|
1894 | 1 |
p. 127 |
artikel |
||
| 117 | Denosumab/pembrolizumab |
|
1894 | 1 |
p. 128 |
artikel |
||
| 118 | Depatuxizumab mafodotin |
|
1894 | 1 |
p. 129 |
artikel |
||
| 119 | Dexamethasone |
|
1894 | 1 |
p. 131 |
artikel |
||
| 120 | Dexamethasone |
|
1894 | 1 |
p. 130 |
artikel |
||
| 121 | Dexamethasone/methylprednisolone |
|
1894 | 1 |
p. 132 |
artikel |
||
| 122 | Dexamethasone/nitric-oxide |
|
1894 | 1 |
p. 133 |
artikel |
||
| 123 | Dexamethasone/tocilizumab |
|
1894 | 1 |
p. 134 |
artikel |
||
| 124 | Dexamethasone/tocilizumab/tofacitinib |
|
1894 | 1 |
p. 135 |
artikel |
||
| 125 | Diazepam/olanzapine |
|
1894 | 1 |
p. 136 |
artikel |
||
| 126 | Diclofenac |
|
1894 | 1 |
p. 137 |
artikel |
||
| 127 | Disease-modifying-antirheumatics/nonsteroidal-anti-inflammatories/steroids |
|
1894 | 1 |
p. 138 |
artikel |
||
| 128 | Doxorubicin/pembrolizumab |
|
1894 | 1 |
p. 139 |
artikel |
||
| 129 | Doxycycline/metronidazole/tranexamic-acid |
|
1894 | 1 |
p. 140 |
artikel |
||
| 130 | Edoxaban/pembrolizumab |
|
1894 | 1 |
p. 141 |
artikel |
||
| 131 | Elasomeran |
|
1894 | 1 |
p. 142 |
artikel |
||
| 132 | Elasomeran |
|
1894 | 1 |
p. 143 |
artikel |
||
| 133 | Elasomeran |
|
1894 | 1 |
p. 144 |
artikel |
||
| 134 | Enoxaparin sodium |
|
1894 | 1 |
p. 145 |
artikel |
||
| 135 | Epinephrine/terbutaline |
|
1894 | 1 |
p. 146 |
artikel |
||
| 136 | Eplerenone/prednisolone |
|
1894 | 1 |
p. 147 |
artikel |
||
| 137 | Etanercept |
|
1894 | 1 |
p. 148 |
artikel |
||
| 138 | Ethionamide/levofloxacin/pyrazinamide |
|
1894 | 1 |
p. 149 |
artikel |
||
| 139 | Etoposide-phosphate |
|
1894 | 1 |
p. 150 |
artikel |
||
| 140 | Etoricoxib |
|
1894 | 1 |
p. 151 |
artikel |
||
| 141 | FAERs, drug manufacturer databases key sources for reporting new drug safety risks |
|
1894 | 1 |
p. 5 |
artikel |
||
| 142 | Fampridine |
|
1894 | 1 |
p. 152 |
artikel |
||
| 143 | Ferric carboxymaltose |
|
1894 | 1 |
p. 153 |
artikel |
||
| 144 | Ferric derisomaltose/aspirin |
|
1894 | 1 |
p. 154 |
artikel |
||
| 145 | Ferumoxtran-10 |
|
1894 | 1 |
p. 155 |
artikel |
||
| 146 | Fingolimod |
|
1894 | 1 |
p. 156 |
artikel |
||
| 147 | Fingolimod/methylprednisolone |
|
1894 | 1 |
p. 157 |
artikel |
||
| 148 | Flucloxacillin/isavuconazole/voriconazole interaction |
|
1894 | 1 |
p. 158 |
artikel |
||
| 149 | Furosemide |
|
1894 | 1 |
p. 159 |
artikel |
||
| 150 | Furosemide |
|
1894 | 1 |
p. 160 |
artikel |
||
| 151 | Gefitinib/osimertinib |
|
1894 | 1 |
p. 162 |
artikel |
||
| 152 | Gefitinib/osimertinib |
|
1894 | 1 |
p. 161 |
artikel |
||
| 153 | Glimepiride |
|
1894 | 1 |
p. 163 |
artikel |
||
| 154 | Haloperidol |
|
1894 | 1 |
p. 164 |
artikel |
||
| 155 | Haloperidol/lorazepam |
|
1894 | 1 |
p. 165 |
artikel |
||
| 156 | Heparin |
|
1894 | 1 |
p. 166 |
artikel |
||
| 157 | Heparin |
|
1894 | 1 |
p. 167 |
artikel |
||
| 158 | Heparin |
|
1894 | 1 |
p. 168 |
artikel |
||
| 159 | Humanized-CD19-chimeric-antigen-receptor-T-cell-therapy/murine-CD19-chimeric-antigen-receptor-T-cell-therapy |
|
1894 | 1 |
p. 169 |
artikel |
||
| 160 | Hydrochlorothiazide/spironolactone/isosorbide dinitrate |
|
1894 | 1 |
p. 170 |
artikel |
||
| 161 | Hydrocodone/hydromorphone/morphine |
|
1894 | 1 |
p. 171 |
artikel |
||
| 162 | Hydrocortisone/prednisolone/tretinoin |
|
1894 | 1 |
p. 172 |
artikel |
||
| 163 | Hydroxycarbamide |
|
1894 | 1 |
p. 174 |
artikel |
||
| 164 | Hydroxycarbamide |
|
1894 | 1 |
p. 173 |
artikel |
||
| 165 | Ibandronic acid |
|
1894 | 1 |
p. 175 |
artikel |
||
| 166 | Ibrutinib |
|
1894 | 1 |
p. 176 |
artikel |
||
| 167 | Ibrutinib/rituximab |
|
1894 | 1 |
p. 177 |
artikel |
||
| 168 | Icotinib |
|
1894 | 1 |
p. 178 |
artikel |
||
| 169 | Ifosfamide/oxaliplatin/niraparib |
|
1894 | 1 |
p. 179 |
artikel |
||
| 170 | Imatinib |
|
1894 | 1 |
p. 180 |
artikel |
||
| 171 | Immune globulin |
|
1894 | 1 |
p. 181 |
artikel |
||
| 172 | Immune-globulin |
|
1894 | 1 |
p. 182 |
artikel |
||
| 173 | Immune-globulin/quetiapine/risperidone |
|
1894 | 1 |
p. 183 |
artikel |
||
| 174 | Immunosuppressants |
|
1894 | 1 |
p. 185 |
artikel |
||
| 175 | Immunosuppressants |
|
1894 | 1 |
p. 186 |
artikel |
||
| 176 | Immunosuppressants |
|
1894 | 1 |
p. 184 |
artikel |
||
| 177 | Immunosuppressants |
|
1894 | 1 |
p. 187 |
artikel |
||
| 178 | Immunosuppressants/tozinameran |
|
1894 | 1 |
p. 188 |
artikel |
||
| 179 | Immunosuppressants/valganciclovir |
|
1894 | 1 |
p. 189 |
artikel |
||
| 180 | Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain |
|
1894 | 1 |
p. 6 |
artikel |
||
| 181 | Interferon-alpha-2b |
|
1894 | 1 |
p. 190 |
artikel |
||
| 182 | Intolerance to initiation of methylphenidate infrequent in children |
|
1894 | 1 |
p. 7 |
artikel |
||
| 183 | Iodine-radioactive |
|
1894 | 1 |
p. 191 |
artikel |
||
| 184 | Ipilimumab/nivolumab |
|
1894 | 1 |
p. 192 |
artikel |
||
| 185 | Ipilimumab/nivolumab/pembrolizumab |
|
1894 | 1 |
p. 193 |
artikel |
||
| 186 | Ipilimumab/nivolumab/tozinameran |
|
1894 | 1 |
p. 194 |
artikel |
||
| 187 | Ixekizumab |
|
1894 | 1 |
p. 195 |
artikel |
||
| 188 | Ko-947/ulixertinib |
|
1894 | 1 |
p. 196 |
artikel |
||
| 189 | Lacosamide |
|
1894 | 1 |
p. 197 |
artikel |
||
| 190 | Lamotrigine |
|
1894 | 1 |
p. 198 |
artikel |
||
| 191 | Lenvatinib |
|
1894 | 1 |
p. 199 |
artikel |
||
| 192 | Lenvatinib |
|
1894 | 1 |
p. 200 |
artikel |
||
| 193 | Levetiracetam overdose |
|
1894 | 1 |
p. 201 |
artikel |
||
| 194 | Levetiracetam/oxcarbazepine/valproate |
|
1894 | 1 |
p. 202 |
artikel |
||
| 195 | Levodopa |
|
1894 | 1 |
p. 203 |
artikel |
||
| 196 | Levofloxacin |
|
1894 | 1 |
p. 204 |
artikel |
||
| 197 | Levosalbutamol overdose |
|
1894 | 1 |
p. 205 |
artikel |
||
| 198 | Levothyroxine sodium/levothyroxine sodium/liothyronine |
|
1894 | 1 |
p. 206 |
artikel |
||
| 199 | Lidocaine |
|
1894 | 1 |
p. 207 |
artikel |
||
| 200 | Linezolid toxicity in patients with drug-resistant TB |
|
1894 | 1 |
p. 8 |
artikel |
||
| 201 | Mefloquine/sulfasalazine |
|
1894 | 1 |
p. 208 |
artikel |
||
| 202 | Methotrexate |
|
1894 | 1 |
p. 210 |
artikel |
||
| 203 | Methotrexate |
|
1894 | 1 |
p. 214 |
artikel |
||
| 204 | Methotrexate |
|
1894 | 1 |
p. 212 |
artikel |
||
| 205 | Methotrexate |
|
1894 | 1 |
p. 213 |
artikel |
||
| 206 | Methotrexate |
|
1894 | 1 |
p. 211 |
artikel |
||
| 207 | Methotrexate |
|
1894 | 1 |
p. 209 |
artikel |
||
| 208 | Methylprednisolone |
|
1894 | 1 |
p. 216 |
artikel |
||
| 209 | Methylprednisolone |
|
1894 | 1 |
p. 215 |
artikel |
||
| 210 | Methylprednisolone/mycophenolate-mofetil/tacrolimus |
|
1894 | 1 |
p. 217 |
artikel |
||
| 211 | Metronidazole |
|
1894 | 1 |
p. 218 |
artikel |
||
| 212 | Misoprostol |
|
1894 | 1 |
p. 219 |
artikel |
||
| 213 | Misoprostol |
|
1894 | 1 |
p. 220 |
artikel |
||
| 214 | Multiple drugs |
|
1894 | 1 |
p. 242 |
artikel |
||
| 215 | Multiple drugs |
|
1894 | 1 |
p. 245 |
artikel |
||
| 216 | Multiple drugs |
|
1894 | 1 |
p. 232 |
artikel |
||
| 217 | Multiple drugs |
|
1894 | 1 |
p. 234 |
artikel |
||
| 218 | Multiple drugs |
|
1894 | 1 |
p. 235 |
artikel |
||
| 219 | Multiple drugs |
|
1894 | 1 |
p. 236 |
artikel |
||
| 220 | Multiple drugs |
|
1894 | 1 |
p. 237 |
artikel |
||
| 221 | Multiple drugs |
|
1894 | 1 |
p. 238 |
artikel |
||
| 222 | Multiple drugs |
|
1894 | 1 |
p. 248 |
artikel |
||
| 223 | Multiple drugs |
|
1894 | 1 |
p. 250 |
artikel |
||
| 224 | Multiple drugs |
|
1894 | 1 |
p. 251 |
artikel |
||
| 225 | Multiple drugs |
|
1894 | 1 |
p. 223 |
artikel |
||
| 226 | Multiple drugs |
|
1894 | 1 |
p. 224 |
artikel |
||
| 227 | Multiple drugs |
|
1894 | 1 |
p. 225 |
artikel |
||
| 228 | Multiple drugs |
|
1894 | 1 |
p. 228 |
artikel |
||
| 229 | Multiple drugs |
|
1894 | 1 |
p. 226 |
artikel |
||
| 230 | Multiple drugs |
|
1894 | 1 |
p. 227 |
artikel |
||
| 231 | Multiple drugs |
|
1894 | 1 |
p. 229 |
artikel |
||
| 232 | Multiple drugs |
|
1894 | 1 |
p. 230 |
artikel |
||
| 233 | Multiple drugs |
|
1894 | 1 |
p. 233 |
artikel |
||
| 234 | Multiple drugs |
|
1894 | 1 |
p. 249 |
artikel |
||
| 235 | Multiple drugs |
|
1894 | 1 |
p. 221 |
artikel |
||
| 236 | Multiple drugs |
|
1894 | 1 |
p. 222 |
artikel |
||
| 237 | Multiple drugs |
|
1894 | 1 |
p. 231 |
artikel |
||
| 238 | Multiple drugs |
|
1894 | 1 |
p. 240 |
artikel |
||
| 239 | Multiple drugs |
|
1894 | 1 |
p. 239 |
artikel |
||
| 240 | Multiple drugs |
|
1894 | 1 |
p. 241 |
artikel |
||
| 241 | Multiple drugs |
|
1894 | 1 |
p. 243 |
artikel |
||
| 242 | Multiple drugs |
|
1894 | 1 |
p. 244 |
artikel |
||
| 243 | Multiple drugs |
|
1894 | 1 |
p. 246 |
artikel |
||
| 244 | Multiple drugs |
|
1894 | 1 |
p. 247 |
artikel |
||
| 245 | Mycophenolate-mofetil/prednisone/tacrolimus |
|
1894 | 1 |
p. 253 |
artikel |
||
| 246 | Mycophenolate mofetil/prednisone/tacrolimus |
|
1894 | 1 |
p. 252 |
artikel |
||
| 247 | Nafamostat |
|
1894 | 1 |
p. 254 |
artikel |
||
| 248 | Nitrazepam/phenytoin/sodium-valproate |
|
1894 | 1 |
p. 255 |
artikel |
||
| 249 | Nivolumab |
|
1894 | 1 |
p. 256 |
artikel |
||
| 250 | Nivolumab |
|
1894 | 1 |
p. 257 |
artikel |
||
| 251 | Nivolumab |
|
1894 | 1 |
p. 258 |
artikel |
||
| 252 | No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine |
|
1894 | 1 |
p. 9 |
artikel |
||
| 253 | Non-serious case reports |
|
1894 | 1 |
p. 312 |
artikel |
||
| 254 | Octreotide |
|
1894 | 1 |
p. 259 |
artikel |
||
| 255 | Oral corticosteroid use increases comorbidities in adults with asthma |
|
1894 | 1 |
p. 10 |
artikel |
||
| 256 | Osimertinib |
|
1894 | 1 |
p. 260 |
artikel |
||
| 257 | Other adverse reaction research |
|
1894 | 1 |
p. 13 |
artikel |
||
| 258 | Oxacillin |
|
1894 | 1 |
p. 261 |
artikel |
||
| 259 | Oxaliplatin/paclitaxel |
|
1894 | 1 |
p. 262 |
artikel |
||
| 260 | Paclitaxel/ramucirumab |
|
1894 | 1 |
p. 263 |
artikel |
||
| 261 | Paracetamol/codeine-phosphate |
|
1894 | 1 |
p. 264 |
artikel |
||
| 262 | Pazopanib |
|
1894 | 1 |
p. 265 |
artikel |
||
| 263 | Pazopanib |
|
1894 | 1 |
p. 266 |
artikel |
||
| 264 | Pazopanib |
|
1894 | 1 |
p. 267 |
artikel |
||
| 265 | PCSK9 inhibitors associated with increase in musculoskeletal adverse events |
|
1894 | 1 |
p. 11 |
artikel |
||
| 266 | Pembrolizumab |
|
1894 | 1 |
p. 270 |
artikel |
||
| 267 | Pembrolizumab |
|
1894 | 1 |
p. 268 |
artikel |
||
| 268 | Pembrolizumab |
|
1894 | 1 |
p. 269 |
artikel |
||
| 269 | Pembrolizumab/trabectedin |
|
1894 | 1 |
p. 271 |
artikel |
||
| 270 | Pemetrexed |
|
1894 | 1 |
p. 272 |
artikel |
||
| 271 | Pertuzumab/trastuzumab |
|
1894 | 1 |
p. 273 |
artikel |
||
| 272 | Piperacillin/tazobactam |
|
1894 | 1 |
p. 274 |
artikel |
||
| 273 | Ponatinib |
|
1894 | 1 |
p. 275 |
artikel |
||
| 274 | Povidone iodine |
|
1894 | 1 |
p. 276 |
artikel |
||
| 275 | Prednisolone |
|
1894 | 1 |
p. 279 |
artikel |
||
| 276 | Prednisolone |
|
1894 | 1 |
p. 280 |
artikel |
||
| 277 | Prednisolone |
|
1894 | 1 |
p. 281 |
artikel |
||
| 278 | Prednisolone |
|
1894 | 1 |
p. 277 |
artikel |
||
| 279 | Prednisolone |
|
1894 | 1 |
p. 278 |
artikel |
||
| 280 | Prednisolone/tirabrutinib |
|
1894 | 1 |
p. 282 |
artikel |
||
| 281 | Prednisone |
|
1894 | 1 |
p. 283 |
artikel |
||
| 282 | Prednisone |
|
1894 | 1 |
p. 284 |
artikel |
||
| 283 | Pregabalin |
|
1894 | 1 |
p. 285 |
artikel |
||
| 284 | Product information for donepezil updated to include warning of cardiac conduction disorders |
|
1894 | 1 |
p. 1 |
artikel |
||
| 285 | Reminder that paclitaxel and nab-paclitaxel not interchangeable |
|
1894 | 1 |
p. 2 |
artikel |
||
| 286 | Risk of SJS/TEN highest with phenytoin, lamotrigine, allopurinol |
|
1894 | 1 |
p. 12 |
artikel |
||
| 287 | Rituximab |
|
1894 | 1 |
p. 287 |
artikel |
||
| 288 | Rituximab |
|
1894 | 1 |
p. 288 |
artikel |
||
| 289 | Rituximab |
|
1894 | 1 |
p. 286 |
artikel |
||
| 290 | Safinamide |
|
1894 | 1 |
p. 289 |
artikel |
||
| 291 | Salbutamol |
|
1894 | 1 |
p. 290 |
artikel |
||
| 292 | Sars-cov-2-vaccine-inactivated-sinovac-biotech |
|
1894 | 1 |
p. 291 |
artikel |
||
| 293 | Secukinumab |
|
1894 | 1 |
p. 292 |
artikel |
||
| 294 | Sulpiride |
|
1894 | 1 |
p. 293 |
artikel |
||
| 295 | Sunitinib |
|
1894 | 1 |
p. 294 |
artikel |
||
| 296 | Sunitinib |
|
1894 | 1 |
p. 295 |
artikel |
||
| 297 | Teriflunomide |
|
1894 | 1 |
p. 296 |
artikel |
||
| 298 | Testosterone |
|
1894 | 1 |
p. 297 |
artikel |
||
| 299 | Tozinameran |
|
1894 | 1 |
p. 298 |
artikel |
||
| 300 | Tozinameran |
|
1894 | 1 |
p. 299 |
artikel |
||
| 301 | Tozinameran |
|
1894 | 1 |
p. 301 |
artikel |
||
| 302 | Tozinameran |
|
1894 | 1 |
p. 302 |
artikel |
||
| 303 | Tozinameran |
|
1894 | 1 |
p. 303 |
artikel |
||
| 304 | Tozinameran |
|
1894 | 1 |
p. 304 |
artikel |
||
| 305 | Tozinameran |
|
1894 | 1 |
p. 305 |
artikel |
||
| 306 | Tozinameran |
|
1894 | 1 |
p. 306 |
artikel |
||
| 307 | Tozinameran |
|
1894 | 1 |
p. 307 |
artikel |
||
| 308 | Tozinameran |
|
1894 | 1 |
p. 308 |
artikel |
||
| 309 | Tozinameran |
|
1894 | 1 |
p. 300 |
artikel |
||
| 310 | Trastuzumab |
|
1894 | 1 |
p. 309 |
artikel |
||
| 311 | Venetoclax |
|
1894 | 1 |
p. 310 |
artikel |
||
| 312 | Warfarin |
|
1894 | 1 |
p. 311 |
artikel |
312 gevonden resultaten